NCT07923526: An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)
- State
- Not started
- Phase
- Phase 2 and Phase 3
- People
- 400 planned
- Started
- Mar 2027
- Primary completion
- Sep 2034
- Arms
- treprostinil SMI
- Results
- None posted
- 6 Nov 2026: Trial registered